MEDPLUSNSEMedplus Health Services LimitedMediumNeutral
Announced Wed, 20 May · 21:58 IST

Medplus Health Services Limited has informed the Exchange regarding re-appointment of Mr. Gangadi Madhukar Reddy as Managing Director & CEO of the company w.e.f. May 20, 2026.

Director Flagged GovernanceManagement Changes View source PDF

MEDPLUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.8%1-day move
₹914.75
prior close
₹975.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7+1.0+3.9+3.5-1.8-1.3-3.0-3.4-1.4-1.5-3.5-8.7-13.5
Up moveDown movePending
AI summary

Medplus Health Services' Board of Directors approved three key appointments at its May 20, 2026 meeting. Two new Non-Executive Independent Directors were appointed: Mr. Ajit Pandurang Rangnekar (former PwC consultant with 50+ years experience) and Mr. Mohankrishna Reddy Arvabama (former CFO at Cyient and AppLabs with 30+ years in finance). Both are appointed for five-year terms subject to shareholder approval. Additionally, promoter-founder Mr. Gangadi Madhukar Reddy was re-appointed as Managing Director for another five years commencing August 3, 2026. All three directors confirmed they are not debarred from holding director positions and have no relationships with existing board members.

Likely market impact

The appointments strengthen the board with experienced independent directors bringing fresh expertise in consulting, finance, and corporate strategy. The re-appointment of the promoter-founder ensures leadership continuity, which is positive for investor confidence in the company's strategic direction.